Effects of Plasma Damage Removal on Direct Contact Resistance and Hot-Electron-Induced Punch Through (HEIP) of PMOSFETs.

In order to reduce contact resistance (Rc) of the source/drain region in nanoscale devices, it is essential to overcome the increasing leakage and hot-electron-induced punch through (HEIP) degradation. In this paper, we propose a simple in situ Si soft treatment technique immediately after direct contact (DC) etching to reduce Rc and minimize HEIP degradation. We found by analysis with a transmission electron microscope, that 10 s of treatment reduced the plasma damaged layer by 19%, which resulted in 10.5% reduction of the P+ contact resistance. For comparison, the P + Rc was reduced by 6.5% when the doping level of the plug implantation was increased by 25%, but the HEIP breakdown voltage (VHEIP) by AC stress was greatly reduced by more than 80 mV, increasing the standby leakage current of DRAM devices. In the case of removing the plasma damage layer, not only did VHIEP not decrease until after 10 s, but also the reduction in Rc was larger than with the plug enhancement. The effect of the plasma damaged layer on HEIP was verified through the plug effect and gate induced drain leakage measurement, based on the distance between the gate and DC for each process. This simple in situ technique not only removed byproducts and the plasma damaged amorphous layer, but it also affected the effective implantation of dopants in subsequent plug processes. It was also cost effective because the process time was short and no extra process steps were added.

Effect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgia.

BACKGROUND/AIMS: Acidic saline injections produce mechanical hyperresponsiveness in male Sprague-Dawley rats. We investigated the effect of milnacipran in conjunction with tramadol on the pain threshold in an acidic saline animal model of pain. METHODS: The left gastrocnemius muscle of 20 male rats was injected with 100 microL of saline at pH 4.0 under brief isoflurane anesthesia on days 0 and 5. Rats administered acidic saline injections were separated into four study subgroups. After determining the pre-drug pain threshold, rats were injected intraperitoneally with one of the following regimens; saline, milnacipran alone (60 mg/kg), milnacipran (40 mg/kg) plus tramadol (20 mg/kg), or milnacipran (40 mg/kg) plus tramadol (40 mg/kg). Paw withdrawal in response to pressure was measured at 30 min, 120 min, and 5 days after injection. Nociceptive thresholds, expressed in grams, were measured with a Dynamic Plantar Aesthesiometer (Ugo Basile, Italy) by applying increasing pressure to the right or left hind paw until the rat withdrew the paw. RESULTS: A potent antihyperalgesic effect was observed when tramadol and milnacipran were used in combination (injected paw, p=0.001; contralateral paw, p=0.012). This finding was observed only at 30 min after the combination treatment. CONCLUSIONS: We observed potentiation of the antihyperalgesic effect when milnacipran and tramadol were administered in combination in an animal model of fibromyalgia. Further research is required to determine the efficacy of various combination treatments in fibromyalgia in humans.